Review


doi: 10.1111/nyas.14930.


Online ahead of print.

Affiliations

Item in Clipboard

Review

Telmah Lluka et al.


Ann N Y Acad Sci.


.

Abstract

As the global burden of antibiotic resistance continues to grow, creative approaches to antibiotic discovery are needed to accelerate the development of novel medicines. A rapidly progressing computational revolution-artificial intelligence-offers an optimistic path forward due to its ability to alleviate bottlenecks in the antibiotic discovery pipeline. In this review, we discuss how advancements in artificial intelligence are reinvigorating the adoption of past antibiotic discovery models-namely natural product exploration and small molecule screening. We then explore the application of contemporary machine learning approaches to emerging areas of antibiotic discovery, including antibacterial systems biology, drug combination development, antimicrobial peptide discovery, and mechanism of action prediction. Lastly, we propose a call to action for open access of high-quality screening datasets and interdisciplinary collaboration to accelerate the rate at which machine learning models can be trained and new antibiotic drugs can be developed.


Keywords:

antibiotics; drug discovery; machine learning.

References

REFERENCES

    1. Murray, C. J., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., Johnson, S. C., Browne, A. J., Chipeta, M. G., Fell, F., Hackett, S., Haines-Woodhouse, G., Kashef Hamadani, B. H., Kumaran, E. A. P., Mcmanigal, B., … Naghavi, M. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629-655.

    1. Antimicrobial resistance: Tackling a crisis for the health and wealth of nations. (2014). Review on Antimicrobial Resistance.

    1. 2021 Antibacterial agents in clinical and preclinical development: An overview and analysis. (2022). Geneva: World Health Organization.

    1. Shlaes, D. M. (2020). Antibacterial drugs: The last frontier. ACS Infectious Diseases, 6, 1313-1314.

    1. Thomas, D., & Wessel, C. (2022). The state of innovation in antibacterial therapeutics. Biotechnology Innovation Organization.